Medical Devices & Consumables
Global Cone-rod Dystrophy Treatment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 04, 25
- ID: 424891
- Pages: 98
- Figures: 97
- Views: 1
The global Cone-rod Dystrophy Treatment market size was US$ 26 million in 2024 and is forecast to a readjusted size of US$ 273 million by 2031 with a CAGR of 24.6% during the forecast period 2025-2031.
Cone dystrophy is an eye disease involving the cones, which are specialized structures in the eye used for color vision. Multiple forms of cone dystrophy have been discovered, and the condition is hereditary in nature. Treatment options focus on helping patients compensate for their vision loss.
The cone-rod dystrophy treatment market is driven by the increasing awareness of genetic retinal diseases and the rising number of patients diagnosed with cone-rod dystrophy (CRD). As CRD leads to progressive vision loss, especially in the central visual field, the demand for effective therapies to slow down or halt the progression of the disease is growing. Advances in genetic research and clinical trials focusing on gene therapies, retinal implants, and other innovative treatments are expected to offer promising solutions for CRD patients. Additionally, the increasing investment in ophthalmology research, as well as improved diagnostic techniques, are contributing to the market’s growth by enabling earlier diagnosis and intervention. As awareness of retinal degenerative diseases rises globally, the focus on providing better treatment options for rare eye conditions like CRD has intensified, attracting investment from both pharmaceutical companies and research institutions.
However, the market faces significant challenges, primarily due to the rarity of cone-rod dystrophy, which limits the overall patient population and slows down the development and commercialization of targeted treatments. The high costs associated with advanced therapies, particularly gene therapy and retinal prosthetics, may also restrict access for patients, especially in lower-income regions. Furthermore, despite the promising progress in treatment options, CRD is a complex disease with various genetic mutations, making the development of a universal treatment difficult. Regulatory approval processes for gene therapies and retinal treatments are long and complicated, adding to the timeline and cost of bringing new treatments to market. Additionally, there remains a need for more extensive clinical data to establish the long-term efficacy and safety of emerging therapies, which could further delay adoption.
Global Cone-rod Dystrophy Treatment includes JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, etc. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific.
The global Cone-rod Dystrophy Treatment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
JCyte
Nanoscope Therapeutics
SparingVision
MeiraGTx
AGTC
Biogen
Second Sight Medical
GlaxoSmithKline
Johnson And Johnson
Sanofi
Pfizer
Novartis
Abbott Laboratories
By Type: (Dominant Segment vs High-Margin Innovation)
Gene Therapy
Stem Cell Therapy
Retinal Implant Surgery
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Ophthalmology Department
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., JCyte in Europe)
- Emerging Product Trends: Gene Therapy adoption vs. Stem Cell Therapy premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Ophthalmology Department potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cone-rod Dystrophy Treatment market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Stem Cell Therapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Ophthalmology Department in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cone-rod Dystrophy Treatment value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Cone dystrophy is an eye disease involving the cones, which are specialized structures in the eye used for color vision. Multiple forms of cone dystrophy have been discovered, and the condition is hereditary in nature. Treatment options focus on helping patients compensate for their vision loss.
The cone-rod dystrophy treatment market is driven by the increasing awareness of genetic retinal diseases and the rising number of patients diagnosed with cone-rod dystrophy (CRD). As CRD leads to progressive vision loss, especially in the central visual field, the demand for effective therapies to slow down or halt the progression of the disease is growing. Advances in genetic research and clinical trials focusing on gene therapies, retinal implants, and other innovative treatments are expected to offer promising solutions for CRD patients. Additionally, the increasing investment in ophthalmology research, as well as improved diagnostic techniques, are contributing to the market’s growth by enabling earlier diagnosis and intervention. As awareness of retinal degenerative diseases rises globally, the focus on providing better treatment options for rare eye conditions like CRD has intensified, attracting investment from both pharmaceutical companies and research institutions.
However, the market faces significant challenges, primarily due to the rarity of cone-rod dystrophy, which limits the overall patient population and slows down the development and commercialization of targeted treatments. The high costs associated with advanced therapies, particularly gene therapy and retinal prosthetics, may also restrict access for patients, especially in lower-income regions. Furthermore, despite the promising progress in treatment options, CRD is a complex disease with various genetic mutations, making the development of a universal treatment difficult. Regulatory approval processes for gene therapies and retinal treatments are long and complicated, adding to the timeline and cost of bringing new treatments to market. Additionally, there remains a need for more extensive clinical data to establish the long-term efficacy and safety of emerging therapies, which could further delay adoption.
Global Cone-rod Dystrophy Treatment includes JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, etc. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific.
The global Cone-rod Dystrophy Treatment market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
JCyte
Nanoscope Therapeutics
SparingVision
MeiraGTx
AGTC
Biogen
Second Sight Medical
GlaxoSmithKline
Johnson And Johnson
Sanofi
Pfizer
Novartis
Abbott Laboratories
By Type: (Dominant Segment vs High-Margin Innovation)
Gene Therapy
Stem Cell Therapy
Retinal Implant Surgery
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Ophthalmology Department
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., JCyte in Europe)
- Emerging Product Trends: Gene Therapy adoption vs. Stem Cell Therapy premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Ophthalmology Department potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cone-rod Dystrophy Treatment market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Stem Cell Therapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Ophthalmology Department in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cone-rod Dystrophy Treatment value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Therapy
1.2.3 Stem Cell Therapy
1.2.4 Retinal Implant Surgery
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ophthalmology Department
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cone-rod Dystrophy Treatment Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Cone-rod Dystrophy Treatment Revenue Market Share by Region (2020-2025)
2.4 Global Cone-rod Dystrophy Treatment Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.2 Europe Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.3 China Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.4 Japan Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Type (2020-2025)
3.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (2026-2031)
3.3 Different Types Cone-rod Dystrophy Treatment Representative Players
4 Breakdown Data by Application
4.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Application (2020-2025)
4.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Cone-rod Dystrophy Treatment Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Cone-rod Dystrophy Treatment Players by Revenue (2020-2025)
5.1.2 Global Cone-rod Dystrophy Treatment Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Cone-rod Dystrophy Treatment Revenue
5.4 Global Cone-rod Dystrophy Treatment Market Concentration Analysis
5.4.1 Global Cone-rod Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Cone-rod Dystrophy Treatment Revenue in 2024
5.5 Global Key Players of Cone-rod Dystrophy Treatment Head office and Area Served
5.6 Global Key Players of Cone-rod Dystrophy Treatment, Product and Application
5.7 Global Key Players of Cone-rod Dystrophy Treatment, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.1.2.2 North America Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.1.3.2 North America Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.2.2.2 Europe Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.2.3.2 Europe Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.3.2.2 China Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.3.3.2 China Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.4.2.2 Japan Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.4.3.2 Japan Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 JCyte
7.1.1 JCyte Company Details
7.1.2 JCyte Business Overview
7.1.3 JCyte Cone-rod Dystrophy Treatment Introduction
7.1.4 JCyte Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.1.5 JCyte Recent Development
7.2 Nanoscope Therapeutics
7.2.1 Nanoscope Therapeutics Company Details
7.2.2 Nanoscope Therapeutics Business Overview
7.2.3 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Introduction
7.2.4 Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.2.5 Nanoscope Therapeutics Recent Development
7.3 SparingVision
7.3.1 SparingVision Company Details
7.3.2 SparingVision Business Overview
7.3.3 SparingVision Cone-rod Dystrophy Treatment Introduction
7.3.4 SparingVision Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.3.5 SparingVision Recent Development
7.4 MeiraGTx
7.4.1 MeiraGTx Company Details
7.4.2 MeiraGTx Business Overview
7.4.3 MeiraGTx Cone-rod Dystrophy Treatment Introduction
7.4.4 MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.4.5 MeiraGTx Recent Development
7.5 AGTC
7.5.1 AGTC Company Details
7.5.2 AGTC Business Overview
7.5.3 AGTC Cone-rod Dystrophy Treatment Introduction
7.5.4 AGTC Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.5.5 AGTC Recent Development
7.6 Biogen
7.6.1 Biogen Company Details
7.6.2 Biogen Business Overview
7.6.3 Biogen Cone-rod Dystrophy Treatment Introduction
7.6.4 Biogen Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.6.5 Biogen Recent Development
7.7 Second Sight Medical
7.7.1 Second Sight Medical Company Details
7.7.2 Second Sight Medical Business Overview
7.7.3 Second Sight Medical Cone-rod Dystrophy Treatment Introduction
7.7.4 Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.7.5 Second Sight Medical Recent Development
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Details
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Cone-rod Dystrophy Treatment Introduction
7.8.4 GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.8.5 GlaxoSmithKline Recent Development
7.9 Johnson And Johnson
7.9.1 Johnson And Johnson Company Details
7.9.2 Johnson And Johnson Business Overview
7.9.3 Johnson And Johnson Cone-rod Dystrophy Treatment Introduction
7.9.4 Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.9.5 Johnson And Johnson Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Details
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Cone-rod Dystrophy Treatment Introduction
7.10.4 Sanofi Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.10.5 Sanofi Recent Development
7.11 Pfizer
7.11.1 Pfizer Company Details
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Cone-rod Dystrophy Treatment Introduction
7.11.4 Pfizer Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.11.5 Pfizer Recent Development
7.12 Novartis
7.12.1 Novartis Company Details
7.12.2 Novartis Business Overview
7.12.3 Novartis Cone-rod Dystrophy Treatment Introduction
7.12.4 Novartis Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.12.5 Novartis Recent Development
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Company Details
7.13.2 Abbott Laboratories Business Overview
7.13.3 Abbott Laboratories Cone-rod Dystrophy Treatment Introduction
7.13.4 Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.13.5 Abbott Laboratories Recent Development
8 Cone-rod Dystrophy Treatment Market Dynamics
8.1 Cone-rod Dystrophy Treatment Industry Trends
8.2 Cone-rod Dystrophy Treatment Market Drivers
8.3 Cone-rod Dystrophy Treatment Market Challenges
8.4 Cone-rod Dystrophy Treatment Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Gene Therapy
1.2.3 Stem Cell Therapy
1.2.4 Retinal Implant Surgery
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ophthalmology Department
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cone-rod Dystrophy Treatment Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Cone-rod Dystrophy Treatment Revenue Market Share by Region (2020-2025)
2.4 Global Cone-rod Dystrophy Treatment Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.2 Europe Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.3 China Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
2.5.4 Japan Cone-rod Dystrophy Treatment Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Type (2020-2025)
3.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (2026-2031)
3.3 Different Types Cone-rod Dystrophy Treatment Representative Players
4 Breakdown Data by Application
4.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Application (2020-2025)
4.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Cone-rod Dystrophy Treatment Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Cone-rod Dystrophy Treatment Players by Revenue (2020-2025)
5.1.2 Global Cone-rod Dystrophy Treatment Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Cone-rod Dystrophy Treatment Revenue
5.4 Global Cone-rod Dystrophy Treatment Market Concentration Analysis
5.4.1 Global Cone-rod Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Cone-rod Dystrophy Treatment Revenue in 2024
5.5 Global Key Players of Cone-rod Dystrophy Treatment Head office and Area Served
5.6 Global Key Players of Cone-rod Dystrophy Treatment, Product and Application
5.7 Global Key Players of Cone-rod Dystrophy Treatment, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.1.2.2 North America Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.1.3.2 North America Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.2.2.2 Europe Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.2.3.2 Europe Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.3.2.2 China Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.3.3.2 China Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Cone-rod Dystrophy Treatment Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Cone-rod Dystrophy Treatment Market Size by Type (2020-2025)
6.4.2.2 Japan Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Cone-rod Dystrophy Treatment Market Size by Application (2020-2025)
6.4.3.2 Japan Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 JCyte
7.1.1 JCyte Company Details
7.1.2 JCyte Business Overview
7.1.3 JCyte Cone-rod Dystrophy Treatment Introduction
7.1.4 JCyte Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.1.5 JCyte Recent Development
7.2 Nanoscope Therapeutics
7.2.1 Nanoscope Therapeutics Company Details
7.2.2 Nanoscope Therapeutics Business Overview
7.2.3 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Introduction
7.2.4 Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.2.5 Nanoscope Therapeutics Recent Development
7.3 SparingVision
7.3.1 SparingVision Company Details
7.3.2 SparingVision Business Overview
7.3.3 SparingVision Cone-rod Dystrophy Treatment Introduction
7.3.4 SparingVision Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.3.5 SparingVision Recent Development
7.4 MeiraGTx
7.4.1 MeiraGTx Company Details
7.4.2 MeiraGTx Business Overview
7.4.3 MeiraGTx Cone-rod Dystrophy Treatment Introduction
7.4.4 MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.4.5 MeiraGTx Recent Development
7.5 AGTC
7.5.1 AGTC Company Details
7.5.2 AGTC Business Overview
7.5.3 AGTC Cone-rod Dystrophy Treatment Introduction
7.5.4 AGTC Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.5.5 AGTC Recent Development
7.6 Biogen
7.6.1 Biogen Company Details
7.6.2 Biogen Business Overview
7.6.3 Biogen Cone-rod Dystrophy Treatment Introduction
7.6.4 Biogen Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.6.5 Biogen Recent Development
7.7 Second Sight Medical
7.7.1 Second Sight Medical Company Details
7.7.2 Second Sight Medical Business Overview
7.7.3 Second Sight Medical Cone-rod Dystrophy Treatment Introduction
7.7.4 Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.7.5 Second Sight Medical Recent Development
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Details
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Cone-rod Dystrophy Treatment Introduction
7.8.4 GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.8.5 GlaxoSmithKline Recent Development
7.9 Johnson And Johnson
7.9.1 Johnson And Johnson Company Details
7.9.2 Johnson And Johnson Business Overview
7.9.3 Johnson And Johnson Cone-rod Dystrophy Treatment Introduction
7.9.4 Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.9.5 Johnson And Johnson Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Details
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Cone-rod Dystrophy Treatment Introduction
7.10.4 Sanofi Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.10.5 Sanofi Recent Development
7.11 Pfizer
7.11.1 Pfizer Company Details
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Cone-rod Dystrophy Treatment Introduction
7.11.4 Pfizer Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.11.5 Pfizer Recent Development
7.12 Novartis
7.12.1 Novartis Company Details
7.12.2 Novartis Business Overview
7.12.3 Novartis Cone-rod Dystrophy Treatment Introduction
7.12.4 Novartis Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.12.5 Novartis Recent Development
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Company Details
7.13.2 Abbott Laboratories Business Overview
7.13.3 Abbott Laboratories Cone-rod Dystrophy Treatment Introduction
7.13.4 Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (2020-2025)
7.13.5 Abbott Laboratories Recent Development
8 Cone-rod Dystrophy Treatment Market Dynamics
8.1 Cone-rod Dystrophy Treatment Industry Trends
8.2 Cone-rod Dystrophy Treatment Market Drivers
8.3 Cone-rod Dystrophy Treatment Market Challenges
8.4 Cone-rod Dystrophy Treatment Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Cone-rod Dystrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Cone-rod Dystrophy Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cone-rod Dystrophy Treatment Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Cone-rod Dystrophy Treatment Revenue Share by Region (2020-2025)
Table 6. Global Cone-rod Dystrophy Treatment Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Cone-rod Dystrophy Treatment Revenue Share Forecast by Region (2026-2031)
Table 8. Global Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2020-2025)
Table 10. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2020-2025)
Table 15. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Cone-rod Dystrophy Treatment Application
Table 18. Global Cone-rod Dystrophy Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cone-rod Dystrophy Treatment Market Share by Players (2020-2025)
Table 20. Global Top Cone-rod Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cone-rod Dystrophy Treatment as of 2024)
Table 21. Ranking of Global Top Cone-rod Dystrophy Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cone-rod Dystrophy Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cone-rod Dystrophy Treatment, Headquarters and Area Served
Table 24. Global Key Players of Cone-rod Dystrophy Treatment, Product and Application
Table 25. Global Key Players of Cone-rod Dystrophy Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 29. North America Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 33. Europe Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 37. China Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 41. Japan Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 43. JCyte Company Details
Table 44. JCyte Business Overview
Table 45. JCyte Cone-rod Dystrophy Treatment Product
Table 46. JCyte Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 47. JCyte Recent Development
Table 48. Nanoscope Therapeutics Company Details
Table 49. Nanoscope Therapeutics Business Overview
Table 50. Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product
Table 51. Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 52. Nanoscope Therapeutics Recent Development
Table 53. SparingVision Company Details
Table 54. SparingVision Business Overview
Table 55. SparingVision Cone-rod Dystrophy Treatment Product
Table 56. SparingVision Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 57. SparingVision Recent Development
Table 58. MeiraGTx Company Details
Table 59. MeiraGTx Business Overview
Table 60. MeiraGTx Cone-rod Dystrophy Treatment Product
Table 61. MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 62. MeiraGTx Recent Development
Table 63. AGTC Company Details
Table 64. AGTC Business Overview
Table 65. AGTC Cone-rod Dystrophy Treatment Product
Table 66. AGTC Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 67. AGTC Recent Development
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Cone-rod Dystrophy Treatment Product
Table 71. Biogen Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 72. Biogen Recent Development
Table 73. Second Sight Medical Company Details
Table 74. Second Sight Medical Business Overview
Table 75. Second Sight Medical Cone-rod Dystrophy Treatment Product
Table 76. Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 77. Second Sight Medical Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Cone-rod Dystrophy Treatment Product
Table 81. GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Johnson And Johnson Company Details
Table 84. Johnson And Johnson Business Overview
Table 85. Johnson And Johnson Cone-rod Dystrophy Treatment Product
Table 86. Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 87. Johnson And Johnson Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Cone-rod Dystrophy Treatment Product
Table 91. Sanofi Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Cone-rod Dystrophy Treatment Product
Table 96. Pfizer Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Cone-rod Dystrophy Treatment Product
Table 101. Novartis Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 102. Novartis Recent Development
Table 103. Abbott Laboratories Company Details
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories Cone-rod Dystrophy Treatment Product
Table 106. Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 107. Abbott Laboratories Recent Development
Table 108. Cone-rod Dystrophy Treatment Market Trends
Table 109. Cone-rod Dystrophy Treatment Market Drivers
Table 110. Cone-rod Dystrophy Treatment Market Challenges
Table 111. Cone-rod Dystrophy Treatment Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Cone-rod Dystrophy Treatment Product Picture
Figure 2. Global Cone-rod Dystrophy Treatment Market Share by Type: 2024 VS 2031
Figure 3. Gene Therapy Features
Figure 4. Stem Cell Therapy Features
Figure 5. Retinal Implant Surgery Features
Figure 6. Global Cone-rod Dystrophy Treatment Market Share by Application: 2024 VS 2031
Figure 7. Hospital
Figure 8. Ophthalmology Department
Figure 9. Other
Figure 10. Cone-rod Dystrophy Treatment Report Years Considered
Figure 11. Global Cone-rod Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cone-rod Dystrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cone-rod Dystrophy Treatment Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Cone-rod Dystrophy Treatment Market Share by Players in 2024
Figure 19. Global Top Cone-rod Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cone-rod Dystrophy Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Cone-rod Dystrophy Treatment Revenue in 2024
Figure 21. North America Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 22. North America Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 23. Europe Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 24. Europe Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 25. China Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 26. China Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 27. Japan Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 28. Japan Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 29. JCyte Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 30. Nanoscope Therapeutics Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 31. SparingVision Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 32. MeiraGTx Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 33. AGTC Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 34. Biogen Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 35. Second Sight Medical Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 36. GlaxoSmithKline Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 37. Johnson And Johnson Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 38. Sanofi Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 39. Pfizer Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 40. Novartis Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 41. Abbott Laboratories Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Table 1. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Cone-rod Dystrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Cone-rod Dystrophy Treatment Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cone-rod Dystrophy Treatment Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Cone-rod Dystrophy Treatment Revenue Share by Region (2020-2025)
Table 6. Global Cone-rod Dystrophy Treatment Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Cone-rod Dystrophy Treatment Revenue Share Forecast by Region (2026-2031)
Table 8. Global Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2020-2025)
Table 10. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2020-2025)
Table 15. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Cone-rod Dystrophy Treatment Application
Table 18. Global Cone-rod Dystrophy Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Cone-rod Dystrophy Treatment Market Share by Players (2020-2025)
Table 20. Global Top Cone-rod Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cone-rod Dystrophy Treatment as of 2024)
Table 21. Ranking of Global Top Cone-rod Dystrophy Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Cone-rod Dystrophy Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Cone-rod Dystrophy Treatment, Headquarters and Area Served
Table 24. Global Key Players of Cone-rod Dystrophy Treatment, Product and Application
Table 25. Global Key Players of Cone-rod Dystrophy Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 29. North America Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 33. Europe Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 37. China Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Cone-rod Dystrophy Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Cone-rod Dystrophy Treatment Revenue Market Share by Company (2020-2025)
Table 41. Japan Cone-rod Dystrophy Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Cone-rod Dystrophy Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 43. JCyte Company Details
Table 44. JCyte Business Overview
Table 45. JCyte Cone-rod Dystrophy Treatment Product
Table 46. JCyte Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 47. JCyte Recent Development
Table 48. Nanoscope Therapeutics Company Details
Table 49. Nanoscope Therapeutics Business Overview
Table 50. Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product
Table 51. Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 52. Nanoscope Therapeutics Recent Development
Table 53. SparingVision Company Details
Table 54. SparingVision Business Overview
Table 55. SparingVision Cone-rod Dystrophy Treatment Product
Table 56. SparingVision Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 57. SparingVision Recent Development
Table 58. MeiraGTx Company Details
Table 59. MeiraGTx Business Overview
Table 60. MeiraGTx Cone-rod Dystrophy Treatment Product
Table 61. MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 62. MeiraGTx Recent Development
Table 63. AGTC Company Details
Table 64. AGTC Business Overview
Table 65. AGTC Cone-rod Dystrophy Treatment Product
Table 66. AGTC Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 67. AGTC Recent Development
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Cone-rod Dystrophy Treatment Product
Table 71. Biogen Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 72. Biogen Recent Development
Table 73. Second Sight Medical Company Details
Table 74. Second Sight Medical Business Overview
Table 75. Second Sight Medical Cone-rod Dystrophy Treatment Product
Table 76. Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 77. Second Sight Medical Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Cone-rod Dystrophy Treatment Product
Table 81. GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Johnson And Johnson Company Details
Table 84. Johnson And Johnson Business Overview
Table 85. Johnson And Johnson Cone-rod Dystrophy Treatment Product
Table 86. Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 87. Johnson And Johnson Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Cone-rod Dystrophy Treatment Product
Table 91. Sanofi Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Cone-rod Dystrophy Treatment Product
Table 96. Pfizer Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Cone-rod Dystrophy Treatment Product
Table 101. Novartis Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 102. Novartis Recent Development
Table 103. Abbott Laboratories Company Details
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories Cone-rod Dystrophy Treatment Product
Table 106. Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (2020-2025) & (US$ Million)
Table 107. Abbott Laboratories Recent Development
Table 108. Cone-rod Dystrophy Treatment Market Trends
Table 109. Cone-rod Dystrophy Treatment Market Drivers
Table 110. Cone-rod Dystrophy Treatment Market Challenges
Table 111. Cone-rod Dystrophy Treatment Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Cone-rod Dystrophy Treatment Product Picture
Figure 2. Global Cone-rod Dystrophy Treatment Market Share by Type: 2024 VS 2031
Figure 3. Gene Therapy Features
Figure 4. Stem Cell Therapy Features
Figure 5. Retinal Implant Surgery Features
Figure 6. Global Cone-rod Dystrophy Treatment Market Share by Application: 2024 VS 2031
Figure 7. Hospital
Figure 8. Ophthalmology Department
Figure 9. Other
Figure 10. Cone-rod Dystrophy Treatment Report Years Considered
Figure 11. Global Cone-rod Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Cone-rod Dystrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cone-rod Dystrophy Treatment Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Cone-rod Dystrophy Treatment Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Cone-rod Dystrophy Treatment Market Share by Players in 2024
Figure 19. Global Top Cone-rod Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cone-rod Dystrophy Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Cone-rod Dystrophy Treatment Revenue in 2024
Figure 21. North America Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 22. North America Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 23. Europe Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 24. Europe Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 25. China Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 26. China Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 27. Japan Cone-rod Dystrophy Treatment Market Share by Type (2020-2025)
Figure 28. Japan Cone-rod Dystrophy Treatment Market Share by Application (2020-2025)
Figure 29. JCyte Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 30. Nanoscope Therapeutics Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 31. SparingVision Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 32. MeiraGTx Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 33. AGTC Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 34. Biogen Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 35. Second Sight Medical Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 36. GlaxoSmithKline Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 37. Johnson And Johnson Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 38. Sanofi Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 39. Pfizer Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 40. Novartis Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 41. Abbott Laboratories Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Tetrabenzyl Thiuram Disulfide Market Research Report 2025
Aug 04, 25
Global Diammonium Phosphate Fertilizer Market Research Report 2025
Aug 04, 25
Global Calcium Nitrate Fertilizer Market Research Report 2025
Aug 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232